Stay updated on IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Sign up to get notified when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.

Latest updates to the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange Detected- Added a government notice about funding and operating status, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference8%

- Check34 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.5%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.5%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference67%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.